$VSEE Key Financial and Operational Highlights for
Post# of 110709
Revenue Growth: telehealth fees surged 196% YoY to $1.44 million and patient fees rose 42% to $0.88 million, driven by expanded ICU and neurocritical care deployments across 25+ hospitals.
Cash Flow Optimization: Net cash used in operations for the nine months ended at $1.52 million, a 46% improvement from $2.82 million in 2024, bolstered by disciplined cost management and $1.69 million in financing inflows.
Balance Sheet Strength: Cash position grew to $0.47 million, with total assets at $18.71 million. Accounts receivable expanded to $2.58 million, signaling robust billing momentum from new contracts.
Strategic Milestones: Full activation of the $10M+ Level 1 hospital teleradiology deal, contributing to over 100,000 radiology reads; AI innovations like SOAP Notes reducing documentation time by 93%; and FedRAMP High status opening doors to billions in federal opportunities through 2030.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
4️⃣Not Financial Advice. What I post is my opinion.
Also Paid for Advertising/IR/PR on Emerging Companies
Full Disclaimer: https://corporateads.com/disclaimer/